OSAHS Screening in Diverse Populations

Condition(s) studied

Investigational drug(s) / intervention(s)

patients with hypertension, diabetes, cardiovascular and cerebrovascular diseases, chronic obstructive pulmonary disease, asthma and other OSA related comorbidities.: In order to explore the prevalence of OSA in patients with different comorbid diseases, this study set up this observation group.

Study summary

The goal of this prospective observational study is to learn about the current prevalence of obstructive sleep apnea-hypopnea syndrome in community population, patients with specific diseases and special population from China. The main question it aims to answer is: (1) What are the prevalence and clinical characteristics of OSA in the community population, the specific disease population and the special population respectively? (2) How about the application value of each OSA screening questionnaire for different populations？Participants will all complete a screening questionnaire, and some will be selected by random sampling to complete either a polysomnography (PSG) or a portable sleep monitor (PM).

Eligibility

Primary outcome measure(s)

• Apnea-Hypopnea Index (AHI) — Baseline
  Collected from polysomnography (PSG) or home sleep apnea testing (PM) for the diagnosis of obstructive sleep apnea (OSA). Unit of Measure: events/hour
• Lowest Oxygen Saturation (Lowest SpO₂) — Baseline
  Collected from PSG or PM to evaluate nocturnal hypoxemia. Unit of Measure: %

Trial sites (2)

Other trials for the same condition